Essential Medical Research

07/20/2026

Tulsa friends… join us today for our COMMUNITY blood drive and help make a life-saving difference! Every donation has the power to save up to three lives, and your generosity could be exactly what someone in our community is waiting for. 

07/08/2026

Come see us Monday July 20th to donate blood and enter a chance to win a $10,000 vacation. 

06/16/2026

06/05/2026

Did you know?
A recent search of ClinicalTrials.gov identified 12 interventional studies for Hidradenitis Suppurativa (HS) conducted across North America, Europe, Asia, and Oceania.

Six of these studies were conducted in the United States.

🔬 Currently, two Phase 2 clinical trials are actively recruiting participants, with enrollment goals of approximately 40 and 90 participants.

Clinical research continues to advance our understanding of HS and may help bring new treatment options to patients in the future.
While there is currently no cure for HS, available treatment options may help reduce symptoms, prevent flare-ups, and improve quality of life. Treatment plans are individualized and may include:
Topical medications for mild HS
Oral antibiotics to help reduce inflammation and infection Hormonal therapies for appropriate patients
Biologic medications that target specific inflammatory pathways
Pain management strategies
Surgical procedures for more advanced disease

Because HS affects each person differently, it is important to work closely with a healthcare provider to determine the most appropriate treatment approach.
✨ Early diagnosis and treatment may help reduce disease progression and scarring.
Follow our page to learn more about HS, treatment options, and ongoing clinical research.

12/07/2025

Some pretty amazing artist in our team at Essential Medical Research.

11/21/2025

With 20+ years of experience, our team is passionate about helping bring groundbreaking treatments to FDA approval—all to help patients live happier, healthier lives. Participants receive study-related care at no cost, including treatments, labs, EKGs, exams, and procedures, along with a stipend for each visit.

Interested? Visit our website for current and upcoming studies. You can reach us anytime via Facebook, email, or phone for questions or support.

11/18/2025

Our site is happy to announce we are open for enrollment in the Lullaby Study! In addition to the Chickenpox vaccine, all patients will also receive 3 additional and FDA approved routine vaccines (including the vaccine for Measles!) and can earn up to $400.
Please reach out to our study coordinators at 918-671-4111 or check out our website at www.emedr.com for more information.



https://www.emedr.com/

Find Your Research Study in the Tulsa and Kansas City Metros Current Enrolling Studies 918.645.1992 Join Essential Medical Research in pioneering innovative

08/22/2025

Next time you’re at the BOK center, keep an eye out for our brand-new Essential Medical Research concourse display.
We would love to see your smiling faces, snap a selfie with a display, and don’t forget to tag us so we can share.


06/30/2025

We are hiring!
Essential Medical Research is looking for a Clinical Research Coordinator to join our dedicated team in Tulsa, OK!

If you’re passionate about advancing medicine, detail-oriented, and thrive in a fast-paced research environment, want to hear from you.
Click here to apply: https://www.emedr.com/careers

Full-time position
Clinical research experience preferred
Work with a team focused on improving patient care through cutting-edge clinical trials

Apply now and help shape the future of healthcare.
📧 To apply, send your resume to [email protected]

We have a mission to be the best-in-class clinical research site contributing to the development of new medications. Become a part of our rapidly growing team located in Tulsa, Oklahoma that will aid in changing peoples lives. We are dedicated to providing the best participant experience during our....

06/27/2025

Survey: What disease area would you like to see a clinical trial available for? Please comment below!